The NMOSD Symposium for health care providers is a comprehensive educational event designed to provide healthcare professionals with the latest insights and advancements in the understanding and management of Neuromyelitis Optica Spectrum Disorder (NMOSD) and Myelin Oligodendrocyte Glycoprotein Disease (MOGAD). This symposium aims to enhance clinical expertise and foster collaboration among neurologists and other healthcare providers involved in the care of patients with NMOSD or MOGAD. Dr. Sylvester and Dr. Leekoff, both recognized specialists, will contribute their expertise to the program, offering valuable perspectives on diagnosis, treatment, and patient care.
Objectives:
The primary objective of this symposium is to provide an in-depth understanding of Neuromyelitis Optica Spectrum Disorder (NMOSD) and Myelin Oligodendrocyte Glycoprotein Disease (MOGAD) to healthcare professionals. The symposium aims to enhance knowledge and clinical practice by focusing on the following key areas:
This symposium is designed to equip physicians with the latest knowledge and tools to enhance patient care and outcomes in NMOSD, fostering a collaborative healthcare environment in New Jersey and beyond.
Featuring:

Neuroimmunologist
Systems Director of the AMG Multiple Sclerosis Center with Specialized Program in Neuromyelitis Optica and MOGAD

Neuroimmunologist
Site Director of the AMG Multiple Sclerosis Center with Specialized Program in Neuromyelitis Optica and MOGAD